Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
T2 Biosystems, Inc. | Chief Commercial Officer | Common Stock | 77 | $12.10 | $0.16 | Feb 20, 2024 | Direct |
T2 Biosystems, Inc. | Chief Commercial Officer | Restricted Stock Units | 13 | $2.05 | $0.16 | Feb 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TTOO | T2 Biosystems, Inc. | Feb 20, 2024 | 2 | $0 | 4 | Feb 20, 2024 | Chief Commercial Officer |
TTOO | T2 Biosystems, Inc. | Nov 8, 2023 | 2 | $0 | 4 | Nov 28, 2023 | Chief Commercial Officer |
TTOO | T2 Biosystems, Inc. | Feb 20, 2023 | 3 | -$349 | 4/A | Nov 28, 2023 | Chief Commercial Officer |
TTOO | T2 Biosystems, Inc. | Nov 8, 2022 | 3 | -$2.32K | 4 | Nov 22, 2022 | Chief Commercial Officer |
TTOO | T2 Biosystems, Inc. | Apr 8, 2022 | 1 | $5.18K | 4 | Apr 11, 2022 | Chief Commercial Officer |
TTOO | T2 Biosystems, Inc. | Feb 26, 2022 | 1 | $0 | 4 | Mar 30, 2022 | Chief Commercial Officer |
TTOO | T2 Biosystems, Inc. | Feb 20, 2022 | 1 | $0 | 4 | Feb 23, 2022 | Chief Commercial Officer |
TTOO | T2 Biosystems, Inc. | Nov 8, 2021 | 0 | $0 | 3/A | Mar 30, 2022 | Chief Commercial Officer |